4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonic acid, 95.0%, 5g

DL-Isoleucine, min 98,5 %, pour la biochimie, 100 g, emballage plastique.

Ethyl [(2-methoxyphenyl)carbamoyl]formate, 97%, 5g

1,1,3,3-Tetramethyl-2-(2-oxopyridin-1(2H)-yl)isouronium hexafluorophosphate, 97%, 1g

Diethyl 2-ethylidenemalonate, 95.0%, 1g

Methyl [4,5-dimethoxy-2-(4-trifluoromethyl-phenylsulfamoyl)-phenyl]-acetate, 99.0%, 1g

PATCHOULI ALCOHOL, 95%, 100mg

2-Bromo-1-(3,5-dichlorophenyl)ethanone, 95.0%, 5g

(4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate, 97.0%, 250mg

Colonne capillaire GC ROTI®Cap-5, 25 m, 0,32 mm, 1,00 µm, 1 pièce(s)

Quinoline-3-sulfonyl chloride, 95.0%, 100mg

1-(4-Fluorophenyl)propan-1-amine hydrochloride, 97.0%, 100mg

Dimethyl benzo[d][1,3]dithiol-2-ylphosphonate, 98%, 250mg